Published on
June 25, 2025
- 10:00 GMT
Altin Biosciences announces US patent approval for its first-in-class, non-hormonal, oral botanical drug candidate.
A non-surgical, non-hormonal drug that is easy to take, easy to tolerate, and preserves fertility is exactly what patients and doctors have demanded for years. EMERYVILLE, CA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Non-hormonal oral …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
